Stem Cell Therapies: Opportunities for Assuring the Quality and Safety of Unregulated Clinical Offerings
This record is part of
a dataset collected by the EU Commission in June-September 2018
. Some of these links will therefore die out with time.
Please see the
overview of courses maintained by ETPLAS
or contact Norecopa for more information.
Owner/Developer: International Society for Stem Cell Research (ISSCR)
United States of America
07 November 2013
United States of America
The International Society for Stem Cell Research (ISSCR), along with the Institute of Medicine and the National Academy of Sciences, is hosting a Washington, DC-based workshop and live webcast examining the practice and consequences of unproven stem cell treatments on November 18, 2013 from 8:30 a.m.-5:30 p.m. EDT. The workshop is free, and registration is open to the public.
Stem cells hold tremendous potential to advance health and medicine, but, to date, only a few clinical applications have been reviewed for safety and efficacy and received regulatory approval. However, clinics have been established throughout the world offering "stem cell therapies" for a wide range of diseases and conditions. Often promoted as established and effective, and sometimes provided at great expense, these treatments have not generally received stringent regulatory oversight, nor have they been tested through rigorous trials to determine safety and likely benefit, and claims remain largely unsubstantiated by medical science.
Optional / Voluntary
Students, Researchers, Regulators and policy-makers, Managers, Scientific officers / Project managers
Academia, Industry, Governmental bodies, Contract Research Organizations (CROs), Consulting, SMEs
Continuing Professional Development
Legislative aspects, In vitro methods
Full coverage (a dedicated course)
|Details on the topic or technology covered:||
Workshop speakers will examine the extent of unsubstantiated treatment offerings and the associated clinical risks and concerns. Discussions will delve into global regulatory and legal landscapes for stem cell trials and treatments and explore a range of potential solutions for assuring the quality of unregulated offerings.
Did you find what you were looking for?Yes, I found it! No, I did not!
Thanks for your feedback! Please note that we cannot respond unless you supply your email address.
What are you looking for?
Please give us your feedback so we can improve the information on the page. Thank you in advance for your help. Please add your email address if you would like a reply.Please contact us by email if you have any questions.